Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Multiple Sclerosis

Free Subscription 29.09.2025 1 Ann Neurol 1 Bone Marrow Transplant 1 Brain 3 J Neurol 1 J Neurol Neurosurg Psychiatry 2 J Neurol Sci 5 Lancet Neurol 4 Mult Scler 1 Neurol Clin Pract 4 Neurology 1 PLoS One

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Ann Neurol

1. SIAVOSHI F, Smith MD, Cassard S, Moreau GB, et al
   Fasting Mimicking Diets Reverse Accelerated Biological Aging in Multiple Sclerosis.
   Ann Neurol. 2025 Sep 19. doi: 10.1002/ana.78044.
   PubMed         Abstract available
   
   

   
   Bone Marrow Transplant

2. VIVEROS-LUGO MA, Cruz-Perez GE, Garcia-Velez D, Chavez-Martinez S, et al
   Predicting the response to hematopoietic stem cell transplantation in persons with multiple sclerosis: the significance of an early positive response.
   Bone Marrow Transplant. 2025 Sep 20. doi: 10.1038/s41409-025-02707.
   PubMed        
   
   

   
   Brain

3. FURLAN R, Schaedelin S, Frederiksen JL, Watanabe M, et al
   Granulocyte and astrocyte markers distinguish MOG-antibody disease and neuromyelitis optica from multiple sclerosis.
   Brain. 2025 Sep 24:awaf345. doi: 10.1093.
   PubMed         Abstract available
   
   

   
   J Neurol

4. HABEK M, Adamec I, Gabelic T, Barun B, et al
   Diagnostic performance of the 2010, 2017, and 2024 McDonald criteria: clinical implications in multiple sclerosis.
   J Neurol. 2025;272:637.
   PubMed         Abstract available
   
   
5. MORENO-NAVARRO L, Mora-Diaz S, Ruiz-Escribano-Menchen L, Sempere AP, et al
   Kappa free light chain index as a diagnostic and prognostic biomarker in multiple sclerosis.
   J Neurol. 2025;272:646.
   PubMed         Abstract available
   
   
6. ROMANO F, Rocca MA, Pagani E, Amato MP, et al
   Effects of cognitive rehabilitation and exercise on brain structure in progressive multiple sclerosis: results from the CogEx trial.
   J Neurol. 2025;272:645.
   PubMed         Abstract available
   
   

   
   J Neurol Neurosurg Psychiatry

7. HEDSTROM AK, Olsson T, Piehl F, Alfredsson L, et al
   Beneficial impact of physical activity on multiple sclerosis disability progression.
   J Neurol Neurosurg Psychiatry. 2025 Sep 23:jnnp-2025-336738.
   PubMed         Abstract available
   
   

   
   J Neurol Sci

8. SIPILA J, Jokela M, Solje E
   Municipality-level incidence of clinically diagnosed amyotrophic lateral sclerosis, multiple sclerosis and Parkinson's disease.
   J Neurol Sci. 2025;478:123696.
   PubMed         Abstract available
   
   
9. MOODY SN, Manuel M, Willette A, Shirtcliff E, et al
   Corrigendum to "The intersection of race and sex on the clinical and cognitive progression of multiple sclerosis" [Journal of the Neurological Sciences, 466 (2024) 123260].
   J Neurol Sci. 2025;478:123697.
   PubMed        
   
   

   
   Lancet Neurol

10. GALETTA SL, Bennett JL
    Shedding new light on the diagnosis of multiple sclerosis.
    Lancet Neurol. 2025;24:807-808.
    PubMed        
    
    
11. FOX RJ, Jones SE
    Translating MRI advances into multiple sclerosis diagnosis: bridging science and clinical practice.
    Lancet Neurol. 2025;24:808-810.
    PubMed        
    
    
12. MONTALBAN X, Lebrun-Frenay C, Oh J, Arrambide G, et al
    Diagnosis of multiple sclerosis: 2024 revisions of the McDonald criteria.
    Lancet Neurol. 2025;24:850-865.
    PubMed         Abstract available
    
    
13. BARKHOF F, Reich DS, Oh J, Rocca MA, et al
    2024 MAGNIMS-CMSC-NAIMS consensus recommendations on the use of MRI for the diagnosis of multiple sclerosis.
    Lancet Neurol. 2025;24:866-879.
    PubMed         Abstract available
    
    
14. SAIDHA S, Green AJ, Leocani L, Vidal-Jordana A, et al
    The use of optical coherence tomography and visual evoked potentials in the 2024 McDonald diagnostic criteria for multiple sclerosis.
    Lancet Neurol. 2025;24:880-892.
    PubMed         Abstract available
    
    

    
    Mult Scler

15. UYSAL TAN F, Tan MO
    Comment on 'short- and mid-term efficacy of sacral neuromodulation in the treatment of neurogenic overactive bladder in patients with multiple sclerosis'.
    Mult Scler. 2025 Sep 22:13524585251380003. doi: 10.1177/13524585251380003.
    PubMed        
    
    
16. CAROLUS B, Dequirez PL, Olivier L, Hafez S, et al
    Response to the letter by Uysal Tan and Tan regarding our article "short- and mid-term efficacy of sacral neuromodulation in the treatment of neurogenic overactive bladder in patients with multiple sclerosis".
    Mult Scler. 2025 Sep 22:13524585251380411. doi: 10.1177/13524585251380411.
    PubMed        
    
    
17. SHIPLEY J, Beadnall HN, Sanfilippo PG, Horakova D, et al
    Disease course after pregnancy in women with progressive multiple sclerosis symptoms.
    Mult Scler. 2025 Sep 20:13524585251368248. doi: 10.1177/13524585251368248.
    PubMed         Abstract available
    
    
18. SALAZAR-CAMELO A, Vega L, Fadlallah Y, Bou Rjeily N, et al
    Finite-course ocrelizumab in relapsing multiple sclerosis: Results of two prospective open-label trials with matched controls.
    Mult Scler. 2025 Sep 19:13524585251375350. doi: 10.1177/13524585251375350.
    PubMed         Abstract available
    
    

    
    Neurol Clin Pract

19. LI P, Lin JK, Klebanoff MJ, Palkar R, et al
    Reducing the Out-of-Pocket Costs of Disease-Modifying Therapies for Medicare Beneficiaries With Multiple Sclerosis.
    Neurol Clin Pract. 2025;15:e200536.
    PubMed         Abstract available
    
    

    
    Neurology

20. OLIVIERI E, Muller J, Toosy AT
    Predicting Disability Using PIRA in Multiple Sclerosis: Is It as Straightforward as It Appears?
    Neurology. 2025;105:e214206.
    PubMed        
    
    
21. PORTACCIO E, Betti M, De Meo E, Pasto L, et al
    Toward a Unified Definition of Progression Independent of Relapse Activity in Multiple Sclerosis.
    Neurology. 2025;105:e213977.
    PubMed         Abstract available
    
    
22. O'NEILL KA, Charvet L, Waltz M, George A, et al
    Cognitive Function in People With Pediatric Multiple Sclerosis Over 2 Years.
    Neurology. 2025;105:e214142.
    PubMed         Abstract available
    
    
23. PORTACCIO E, Amato MP
    Moving Closer to the Prevention of Cognitive Disability in People With Pediatric-Onset Multiple Sclerosis.
    Neurology. 2025;105:e214244.
    PubMed        
    
    

    
    PLoS One

24. LI L, Olcer M, Wang Z, Song Y, et al
    IFN-beta therapy rescues dysregulated IFN-stimulated proteins, serum cytokines, and neurotrophic factors in multiple sclerosis: Multiplex analysis of short-term and long-term IFN responses.
    PLoS One. 2025;20:e0330867.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Multiple Sclerosis is free of charge.